A phase I study conducted with recurrent prostate cancer patients with elevated prostate-specific antigen levels evaluated the effects of the administration of pulverized muscadine grape skin extract containing resveratrol (4000 mg). This evidence concerns the gene KLK3 and Familial prostate cancer.